|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Dyne Therapeutics (NASDAQ: DYN) through any online brokerage.
There are no as such competitors for Dyne Therapeutics.
The latest price target for Dyne Therapeutics (NASDAQ: DYN) was reported by JP Morgan on 2020-10-12. The analyst firm set a price target for 27.00 expecting DYN to rise to within 12 months (a possible 73.08% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Dyne Therapeutics (NASDAQ: DYN) is $15.6 last updated Fri Mar 05 2021 21:00:01 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Dyne Therapeutics.
There is no upcoming split for Dyne Therapeutics.